Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 2
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01100385Not ApplicableCompleted

TomVasc - Vascular Effects of Tomato Extract

Role: collaborator

NCT00939237Phase 3Completed

Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

Role: collaborator

NCT01199549Completed

Bioavailability Study of Different Dietary Antioxidants in Volunteers

Role: lead

NCT00905931Phase 2Unknown

Lycopene Following Aneurysmal Subarachnoid Haemorrhage

Role: collaborator

All 4 trials loaded